Mark Cleveland, MD
Dermatology · Cedar Rapids, IANPI 1720086523
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $300 of the $500 with a category attached, or 60.0%. 5 manufacturers reported payments, led by Johnson & Johnson at 59.8% of the total. That places this record below the midpoint for dermatology clinicians in IA, where the typical reported total is $716.
Across 8 payments — averaging $62.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$299
- UCB, Inc.$115
- Novartis$37
- AbbVie$33
- Sanofi$16
What the payments were for
- Food & beverage$30060%
- Education$20040%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 3 | $299 |
| UCB, Inc. | 1 | $115 |
| Novartis | 2 | $37 |
| AbbVie | 1 | $33 |
| Sanofi | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Bimzelx$115
How this compares
$500 in reported general payments places this provider in the 40th percentile of 92 dermatology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enbrel SureclickEtanercept | 13 | $180,724 |
| Humira(Cf) PenAdalimumab | 22 | $151,003 |
| SotyktuDeucravacitinib | 20 | $126,162 |
| OtezlaApremilast | 20 | $102,900 |
| Dupixent PenDupilumab | 20 | $87,717 |
| Mometasone Furoate | 234 | $5,174 |
| Betamethasone Dipropionate | 81 | $4,074 |
| Clobetasol Propionate | 69 | $3,530 |
| Triamcinolone Acetonide | 219 | $2,766 |
| Fluorouracil | 28 | $2,705 |
| Ketoconazole | 159 | $2,345 |
| Metronidazole | 49 | $2,033 |
| Hydroxychloroquine Sulfate | 69 | $2,016 |
| MethotrexateMethotrexate Sodium | 81 | $1,386 |
| Calcipotriene | 13 | $1,244 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Cedar Rapids
- David KnutsonCedar Rapids$60K
- John WollnerCedar Rapids$2K
- Lauren DoughtymcdonaldCedar Rapids$1K
- Stacy KirbyCedar Rapids$863
- Emily BoesCedar Rapids$503
- Matthew LandherrCedar Rapids$413
- Roger CeilleyWest Des Moines$82K
- Scott GreenFort Dodge$56K
- Timothy AbrahamsonUrbandale$49K
- Ali JabbariIowa City$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.